TOR Synthetic Peptide, PEP-0241, from Invitrogen.
TOR Synthetic Peptide, PEP-0241, from Invitrogen.
FRAP1 (mTOR) is a serine/threonine kinase that plays a critical role in cellular growth and proliferation. Perturbations in the mTOR/PI3-kinase/AKT pathway are associated with numerous forms of cancer. FRAP1 is also the target of rapamycin and its analogues, which are currently used as immunosuppressants and cancer therapeutics. Mutations affecting the gene results in Smith-Kingsmore syndrome.
Conservation
Storage: -20°C.
Formulation
Concentration: 200 μg/mL.
Regulatory status
Research only (RUO).
Packaging
Packaging: 50 μg.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15246459 |
| Specifications |
| Gene ID (Enter) | 2475 |
| Species | Human |
| Purification method | Purified |
| Accession number | P42345 |
| Common name | Human mTOR |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | MTOR |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
Origin and customs
| Manufacturer ref. | PEP-0241 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3824 99 96 00 |
|---|
A question or a specific configuration?
Contact us for a quote.